Term
|
Definition
UT I and Nocardiosis (an infection in the lungs) |
|
|
Term
|
Definition
|
|
Term
|
Definition
Strep pneumonia, meningitis, endocarditis, anthrax |
|
|
Term
Cephlasporins, 1st generation |
|
Definition
|
|
Term
Cephlasporins 2nd generation |
|
Definition
UTI, and lower respiratory infection |
|
|
Term
Cephlasporins, 3rd generation |
|
Definition
CSF infection (like meningitis), nosocomial infections |
|
|
Term
Cephlasporins, 4 th generation |
|
Definition
Complete roll to be discovered. Empiric therapy for febrile neutropenic patients, and moderate to severe pneumonia. |
|
|
Term
|
Definition
Bone, joint, skin, and soft tissue (complicated body cavity infections) |
|
|
Term
|
Definition
Single dose therapy in women for UTI from e coli or enterococcus faecalis. |
|
|
Term
|
Definition
Severe systemic infections and UTI |
|
|
Term
|
Definition
Lyme' s disease, Rickettsia, syphilis, Rocky Mountain spotted fever |
|
|
Term
|
Definition
|
|
Term
|
Definition
Lower respiratory infection, bone and joint, UTI, STD, anthrax |
|
|
Term
|
Definition
MRSA, patients with penicillin allergies, C-diff |
|
|
Term
|
Definition
Respiratory tract infections, skin and soft tissue infections and peritonitis |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
Upper respiratory infection |
|
|
Term
|
Definition
Mild to moderate upper respiratory infection |
|
|
Term
|
Definition
Vanco resistant E. Faecium, MRSA, drug resistant strep, pneumoniae |
|
|
Term
|
Definition
|
|
Term
|
Definition
Only for life-threatening infections due to the risk of aplastic anemia and other blood dyscrasias |
|
|
Term
|
Definition
Typical therapy for impetigo caused by strep pyogenes |
|
|
Term
|
Definition
Impetigo caused by strep pyogenes and elimination of nasal colonization by MRSA |
|
|
Term
|
Definition
Bloodstream infections with staph and complicated skin and structure infections with MRSA. |
|
|
Term
|
Definition
TB and asymptomatic carriers of Neisseria meningitis |
|
|